v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Commercialization revenue $ 120,772 $ 128,940
Total revenue 120,772 128,940
Costs and operating expenses:    
Cost of commercialization revenue 21,212 21,009
Research and development expenses 37,445 151,483
General and administrative expenses 26,253 39,886
Total costs and operating expenses 84,910 212,378
Loss from operations 35,862 (83,438)
Other income (expense), net:    
Interest income 683 2,110
Interest expense (3,792) (4,615)
Other income (expense), net: (34) 528
Total other income (expense), net (3,143) (1,977)
Loss before provision for (benefit from) income taxes 32,719 (85,415)
Provision for (benefit from) income taxes 31 (12)
Net loss 32,688 (85,403)
Other comprehensive gain (loss):    
Unrealized gain (loss) on available-for-sale securities (7) 212
Comprehensive loss $ 32,681 $ (85,191)
Net loss per common share:    
Basis net loss per common share $ 2.61 $ (11.41)
Diluted net loss per common share $ 2.57 $ (11.41)
Basic weighted-average shares outstanding 12,544 7,488
Diluted weighted-average shares outstanding 12,718 7,488

Source

10-K
HTML PDF
XBRL
ZIP